InvestorsHub Logo

The Other Guy

01/06/22 1:44 PM

#35075 RE: DonDonDonDon #35072

I agree. Activ 5 data will gain an EUA, MHRA and potentially a CMA with Europe. My concern is inventory and how quickly it can be made. If the US and UK both approved Lenz simultaneously, I don’t think 100k treatments is enough. Having shut down production after September, what would it take to ramp it up to match demand?